US Stock MarketDetailed Quotes
TCBP TC BioPharm
- 1.6450
- +0.0650+4.11%
Trading Apr 23 09:55 ET
5.26MMarket Cap-69P/E (TTM)
1.6700High1.5400Low44.44KVolume1.5500Open1.5800Pre Close70.98KTurnover1.92%Turnover RatioLossP/E (Static)3.20MShares26.600052wk High1.59P/B3.81MFloat Cap0.850152wk Low--Dividend TTM2.31MShs Float3500.0000Historical High--Div YieldTTM8.23%Amplitude0.8501Historical Low1.5970Avg Price1Lot Size
About TC BioPharm Company
TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.
Company Profile
SymbolTCBP
Company NameTC BioPharm
Listing DateFeb 11, 2022
Issue Price4.24
Founded2013
CEOMr. Bryan Kobel
MarketNASDAQ
Employees41
Securities TypeDR
ADS Ratio1.0 : 20.0
Fiscal Year Ends12-31
AddressMaxim Park 1,2 Parklands Way,Holytown
CityMotherwell
ProvinceNK
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeML1 4WR
Phone44-141-433-7557
Websitehttp://www.tcbiopharm.com
Company Executives
- Name
- Position
- Salary
- Bryan Kobel
- Chief Executive Officer and Director
- --
- Martin Thorp
- Chief Financial Officer and Director
- --
- Edward Niemczyk
- Chairman of the Board
- --
- Dr. Mark Bonyhadi
- Director
- --
- Arlene M. Morris
- Independent Director
- --
- Anthony James Culverwell
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg